Diagnosis and treatment of orbital optic nerve sheath meningioma

Cancer Control

Volumn 11, Issue 5, 2004, Pages 334-341

  Turbin, Roger E ^a,b   Pokorny, Kathryn ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ANTINEOPLASTIC AGENT; CILENGITIDE; CONTRAST MEDIUM; CYCLOPHOSPHAMIDE; DACARBAZINE; DOXORUBICIN; ERLOTINIB; GADOLINIUM; GEFITINIB; HYDROXYUREA; IFOSFAMIDE; IMATINIB; LONAFARNIB; MESNA; MIFEPRISTONE; OCTREOTIDE; PENTETREOTIDE IN 111; TAMOXIFEN; TEMOZOLOMIDE; VINCRISTINE;

ALOPECIA; BLINDNESS; BRAIN ATROPHY; BRAIN NECROSIS; CANCER DIAGNOSIS; CANCER GROWTH; CANCER RADIOTHERAPY; CANCER SURGERY; CARCINOGENESIS; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CRANIAL NEUROPATHY; DECOMPRESSION SURGERY; DIFFERENTIAL DIAGNOSIS; DRY EYE; ECHOOCULOGRAPHY; EDEMA; ERYTHEMA; HEARING LOSS; HISTOPATHOLOGY; HUMAN; HYPOPHYSIS DISEASE; IRITIS; MENINGIOMA; NAUSEA; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTIC NERVE DISEASE; OPTIC NERVE TUMOR; ORBIT TUMOR; PAIN; PROGNOSIS; RADIATION CATARACT; RADIATION INDUCED EMESIS; RADIOGRAPHY; RETINOPATHY; REVIEW; SCINTIGRAPHY; SEX DIFFERENCE; SYMPTOMATOLOGY; TEMPORAL LOBE; TUMOR BIOPSY; VASCULAR DISEASE;

EID: 14644390829     PISSN: 10732748     EISSN: None     Source Type: Journal    
DOI: 10.1177/107327480401100508     Document Type: Review

References (46)

1. Dutton JJ. Optic nerve gliomas and meningiomas. Neurol Clin. 1991;1:163-177.
2. Saeed P, Rootman J, Nugent RA, et al. Optic nerve sheath meningiomas. Ophthalmology. 2003;110:2019-2030.
3. Karp LA, Zimmerman LE, Borit A, et al. Primary intraorbital meningiomas. Arch Ophthalmol. 1974;91:24-28.
4. Miller NR, Newman NJ, eds. Walsh & Hoyt's Clinical Neuro-Ophthalmology. 5th ed. Baltimore, Md: Williams & Wilkins; 1998.
5. Spencer WH. Primary neoplasms of the optic nerve and its sheaths: clinical features and current concepts of pathogenetic mechanisms. Trans Am Ophthalmol Soc. 1972;70:490-528.
6. Kennerdell JS, Maroon JC, Malton M, et al. The management of optic nerve sheath meningiomas. Am J Opthalmol. 1988;106:450-457.
7. Wright JE. Primary optic nerve meningiomas: clinical presentation and management. Trans Am Acad Opthalmol Otolaryngol. 1977;83(4 pt 1);617-625.
8. Cameron EW. Transient ischaemic attacks due to meningioma: report of 4 cases. Clin Radiol. 1994;49:416-418.
9. Sibony PA, Krauss HR, Kennerdell JS, et al. Optic nerve sheath meningiomas: clinical manifestations. Ophthalmology. 1984;91:1313-1326.
10. Frisen L, Hoyt WF, Tengroth BM. Optociliary veins, disc pallor and visual loss: a triad of signs indicating spheno-orbital meningioma. Acta Ophthalmol (Copenh). 1973;51:241-249.
11. Knight CL, Hoyt WF, Wilson CB. Syndrome of incipient prechiasmal optic nerve compression. Progress toward early diagnosis and surgical management. Arch Ophthalmol. 1972;87:1-11.
12. Kennerdell JS, Maroon JC. Intracanalicular meningioma with chronic optic disc edema. Ann Ophthalmol. 1975;7:507-512.
13. Mark LE, Kennerdell JS, Maroon JC, et al. Microsurgical removal of a primary intraorbital meningioma. Am J Ophthalmol. 1978;86:704-709.
14. Byrne SF, Green RL. Ultrasound of the Eye and Orbit. St. Louis, Mo: Mosby; 2002.
15. Mafee MF, Goodwin J, Dorodi S. Optic nerve sheath meningiomas; role of MR imaging. Radiol Clin North Am. 1999;37:37-58, ix. Review.
16. Trobe JD, Glaser JS, Post JD, et al. Bilateral optic canal meningiomas: a case report. Neurosurgery. 1978;3:68-74.
17. Egan RA, Lessell S. A contribution to the natural history of optic nerve sheath meningiomas. Arch Ophthalmol. 2002;120:1505-1508.
18. Turbin RE, Thompson CR, Kennerdell JS, et al. A long-term visual outcome comparison in patients with optic nerve sheath meningioma managed with observation, surgery, radiotherapy, or surgery and radiotherapy. Ophthalmology. 2002;109:890-899.
19. D'Alena PR. Primary orbital meningioma. Arch Ophthlmol. 1964;1:832-833.
20. Tan KK, Lim AS. Primary extradural intra-orbital meningioma in a Chinese girl. Br J Ophthalmol. 1965;49:377-380.
21. Shuangshoti S. Meningioma of the optic nerve. Br J Ophthalmol. 1973;57:265-269.
22. Benedict WL. Tumors and cysts arising near the apex of the orbit. Am J Ophthalmol. 1922;6:183-201.
23. Pitz S, Becker G, Schiefer U, et al. Stereotactic fractionated irradiation of optic nerve sheath meningioma: a new treatment alternative. Br J Ophthalmol. 2002;86:1265-1268.
24. Becker G, Jeremic B, Pitz S, et al. Stereotactic fractionated radiotherapy in patients with optic nerve sheath meningioma. Int J Radiat Oncol Biol Phys. 2002;54:1422-1429.
25. Andrews DW, Faroozan R, Yang BP, et al. Fractionated stereotactic radiotherapy for the treatment of optic nerve sheath meningiomas: preliminary observations of 33 optic nerves in 30 patients with historical comparison to observation with or without prior surgery. Neurosurgery. 2002;51:890-904.
26. Alper MG. Management of primary optic nerve meningiomas. Current status: therapy in controversy. J Clin Neuroophthalmol. 1981;1:101-117.
27. Newell FW, Beamon TC. Ocular signs of meningiomas. Am J Ophthalmol. 1958;45:30-40.
28. Wan WL, Geller JL, Feldon SE, et al. Visual loss caused by rapidly progressive intracranial meningiomas during pregnancy. Ophthalmology. 1990;97:18-21.
29. Maxwell M, Galanopoulos T, Neville-Golden J, et al. Expression of androgen and progesterone receptors in primary human meningiomas. J Neurosurg. 1993;78:456-462.
30. Miller NR. Radiation for optic nerve meningiomas: is this the answer? Ophthalmology. 2002;109:833-834.
31. Miller NR. The evolving management of optic nerve sheath meningiomas. Br J Ophthalmol. 2002;86:1198.
32. Liu JK, Forman S, Hershewe GL, et al. Optic nerve sheath meningiomas: visual improvement after stereotactic radiotherapy. Neurosurgery. 2002;50:950-957.
33. Moyer PD, Golnik KC, Breneman J. Treatment of optic nerve sheath meningioma with three-dimensional conformal radiation. Am J Ophthalmol. 2000;129:694-696.
34. Kupersmith MJ, Warren FA, Newall J, et al. Irradiation of meningiomas of the intracranial anterior visual pathway. Ann Neurol. 1987;21:131-137.
35. Smith JL, Vuksanovic MM, Yates BM, et al. Radiation therapy for primary optic nerve meningiomas. J Clin Neuroophthalmol. 1981;1:85-99.
36. Baumert BG, Norton IA, Davis JB. Intensity-modulated stereotactic radiotherapy vs stereotactic conformal radiotherapy for the treatment of meningioma located predominantly in the skull base. Int J Radiat Oncol Biol Phys. 2003;57:580-592.
37. Narayan S, Cornblath WT, Sandler HM, et al. Preliminary visual outcomes after three-dimensional conformal radiation therapy for optic nerve sheath meningioma. Int J Radiat Oncol Biol Phys. 2003;56:537-543.
38. Augspurger ME, Teh BS, Uhl BM, et al. Conformal intensity modulated radiation therapy for the treatment of optic nerve sheath meningioma. Int J Radiat Oncol Biol Phys. 1991;45S:324.
39. Tsao MN, Hoyt WF, Horton J, et al. Improved visual outcome with definitive radiation therapy for optic nerve sheath meningioma. Int J Radiat Oncol Biol Phys. 1991;45S:324-325.
40. Al-Mefty O, Kersh JE, Routh A, et al. The long-term side effects of radiation therapy for benign brain tumors in adults. J Neurosurg. 1990;73:502-512.
41. Capo H, Kupersmith MJ. Efficacy and complications of radiotherapy of anterior visual pathway tumors. Neurol Clin. 1991;9:179-203.
42. Subramanian PS, Bressler NM, Miller NR. Radiation retinopathy after fractionated stereotactic radiotherapy for optic nerve sheath meningioma. Ophthalmology. 2004;111:565-567.
43. Wladis EJ, Turbin RE, Langer PD, et al. Salvage therapy for ONSM. Presented at the American Academy of Ophthalmology; November 15-18, 2003; Anaheim, Calif.
44. Chamberlain MC. Meningiomas. Curr Treat Options Neurol. 2001;3:67-76.
45. Kyritsis AP. Chemotherapy for meningiomas. J Neurooncol. 1996;29:269-272.
46. Paus S, Klockgether T, Urbach H, et al. Meningioma of the optic nerve sheath: treatment with hydroxyurea. J Neurol Neurosurg Psychiatry. 2003;74;1348-1350.